1 ETF With a 31% Allocation to SpaceX

The Baron First Principles ETF has 31% of assets in SpaceX, an unusually concentrated bet that the article argues is too risky for long-term investors. While SpaceX fits the fund’s disruptive-innovation mandate, the lack of diversification and limited operating history raise concerns about volatility and drawdown risk. The piece’s recommendation is effectively to avoid the fund rather than buy it.

Analysis

This is less a statement about SpaceX than about how far investors are willing to stretch wrapper risk to access a scarce asset. When a single private-name exposure becomes the de facto anchor of an ETF, the fund stops behaving like a diversified vehicle and starts trading like a marked-up venture proxy with daily liquidity, which is a structurally unstable combination in a risk-off tape. The second-order effect is that the vehicle can attract momentum flows precisely when the underlying asset is most expensive, leaving late buyers exposed to both valuation compression and liquidity mismatch.

The main catalyst is not operating performance alone but any change in the private-market access regime. If direct secondary liquidity improves or competing vehicles emerge, the scarcity premium supporting the fund's concentration can fade over 3-12 months, and the wrapper’s appeal weakens faster than the underlying business thesis. Conversely, a successful IPO or broader risk-on rotation would help, but only if public-market investors are willing to underwrite a growth multiple above the private-market clearing price.

The contrarian read is that the market may be over-discounting the concentration risk because the headline story is compelling. But for allocators, the real hazard is path dependency: a 20-30% drawdown in the core holding can easily translate into a much larger fund-level drawdown due to compounding, redemptions, and forced selling in a thinly diversified portfolio. That makes this more attractive as a sentiment gauge than as a core holding.

Key Decisions for Investors

• Avoid initiating a core long in RONB; if exposure is required, use a small tactical position only after a 10-15% pullback in the underlying private asset proxy, with a hard stop tied to further concentration increases.
• For investors seeking innovation exposure, prefer a diversified basket of listed disruptors over concentrated private-market wrappers; pair long QQQ or ARKK with a short in RONB on any premium expansion as a hedge against sentiment reversal over the next 1-3 months.
• If a liquid hedge is needed against private-market exuberance, short high-beta innovation ETFs or buy put spreads on RONB into strength; the risk/reward improves when flows chase the story rather than when the name is already de-rated.
• Monitor secondary-market pricing and any IPO timing updates; if direct access expands, expect the scarcity premium to compress within 1-2 quarters, which would favor reducing exposure ahead of that inflection.